IGF1 and retinopathy of prematurity: A variety of factors have been found to be involved in neovascularization, such as vascular endothelial growth factor, insulin-like growth factor-1, epidermal growth factor, etc. At present, the treatment of ROP mainly includes laser therapy, anti-vascular endothelial growth factor drug therapy, scleral cerclage and vitrectomy (13).